QuantiFERON Change During Anti-tuberculosis Medication
The aim of this study is to evaluate the change of QuantiFERON-TB gold in tube assay (QFT) during the treatment of active tuberculosis.
Interferon-gamma Release Assay
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||The Change in Level of Interferon-gamma Assay in Active Tuberculosis Patients During Treatment|
|Study Start Date:||May 2008|
|Study Completion Date:||May 2010|
|Primary Completion Date:||April 2010 (Final data collection date for primary outcome measure)|
Patients with active pulmonary tuberculosis are enrolled and, QFTs are performed for each subjects before treatment and 1, 3, 6 months after treatment. Investigators check the level of interferon-gamma, and reversion and conversion of this test.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01038830
|Korea, Republic of|
|Armed Forces Capital Hospital|
|Seongnam, Gyeonggi-do, Korea, Republic of, 463-040|